Here's the live share price of Colinz Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Colinz Laboratories | 9.47 | 15.3 | -3.72 | 11.67 | -0.48 | 7.52 | 41.79 |
| Sun Pharmaceutical Industries | -2.36 | -8.73 | -4.73 | -0.97 | -1.95 | 17.94 | 21.73 |
| Divi's Laboratories | 4.23 | -4.18 | -5.91 | -5.76 | 9.16 | 28.02 | 10.04 |
| Torrent Pharmaceuticals | 4.43 | -5.88 | 5.51 | 17.77 | 33.2 | 38.26 | 26.66 |
| Lupin | 2.46 | -0.34 | 6.53 | 19.04 | 18.47 | 52.09 | 17.41 |
| Dr. Reddy's Laboratories | 1.18 | -6.23 | 1.34 | -2.59 | 11.08 | 8.99 | 4.31 |
| Cipla | 3.03 | -7.76 | -16.13 | -21.26 | -15.96 | 10.89 | 6.37 |
| Zydus Lifesciences | 5.87 | -0.86 | 2.23 | -7.9 | 5.38 | 22.6 | 12.85 |
| Mankind Pharma | 4.38 | -6.83 | -6.37 | -15.2 | -11.33 | 13.55 | 7.92 |
| Aurobindo Pharma | 1.13 | 5.07 | 15.21 | 19.49 | 24.8 | 35.7 | 8.08 |
| Alkem Laboratories | 3.48 | -3.19 | -7.3 | -0.24 | 11.46 | 17.29 | 14.66 |
| Glenmark Pharmaceuticals | 3.21 | -3 | 7.1 | 11.46 | 56.91 | 64.24 | 34.1 |
| Laurus Labs | 4.95 | 5.64 | 5.14 | 24.98 | 80.8 | 53.31 | 21.36 |
| Biocon | -1.12 | -11.89 | -6.3 | -1.22 | 10.12 | 17.38 | -2.91 |
| Abbott India | -1.47 | -3.77 | -8.88 | -14.2 | -12.47 | 4.32 | 11.45 |
| Anthem Biosciences | 12.22 | 10.75 | 20.14 | -7.27 | 1.6 | 0.53 | 0.32 |
| GlaxoSmithKline Pharmaceuticals | 3.44 | -4.08 | -0.36 | -13.53 | -13 | 22.77 | 10.45 |
| Ipca Laboratories | -1.95 | -2.23 | -4.67 | 9.2 | 9.41 | 20.45 | 6.23 |
| Ajanta Pharma | 0.11 | -6.73 | 2.35 | 14.94 | 9.02 | 29.49 | 19.64 |
| J B Chemicals & Pharmaceuticals | 2.43 | -5.45 | 6.78 | 19.66 | 27.27 | 25.08 | 26.91 |
Over the last one year, Colinz Laboratories has declined 0.48% compared to peers like Sun Pharmaceutical Industries (-1.95%), Divi's Laboratories (9.16%), Torrent Pharmaceuticals (33.20%). From a 5 year perspective, Colinz Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (21.73%) and Divi's Laboratories (10.04%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 43.64 | 44.37 |
| 10 | 44.17 | 44.14 |
| 20 | 43.4 | 44.72 |
| 50 | 51.59 | 47.4 |
| 100 | 48.97 | 48.22 |
| 200 | 46.33 | 48.75 |
In the latest quarter, Colinz Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 34.00% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Apr 03, 2026, 06:05 AM IST IST | Colinz Laboratories - Declaration Of Non-Applicability Of Reg. 32 Of The SEBI (LODR) Regulations, 2015 (Statement Of Deviatio |
| Apr 03, 2026, 05:59 AM IST IST | Colinz Laboratories - Non - Applicability Of Annual Secretarial Compliance Report Under Regulation 24A Of SEBI (LODR) Regulat |
| Apr 03, 2026, 05:53 AM IST IST | Colinz Laboratories - Declaration With Respect To Non-Applicability Of Related Party Transactions Pursuant To Regulations 23( |
| Apr 03, 2026, 05:49 AM IST IST | Colinz Laboratories - Confirmation Of Not Being Identified As Large Corporate In Terms Of SEBI Circular No. SEB |
| Jan 24, 2026, 11:57 PM IST IST | Colinz Laborator - Outcome Of The Board Meeting Under Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requir |
Colinz Laboratories Ltd. is a Public Limited Listed company incorporated on 06/10/1986 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24200MH1986PLC041128 and registration number is 041128. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 6.53 Cr. and Equity Capital is Rs. 2.52 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Colinz Laboratories is ₹47.85 as on Apr 10, 2026.
The Colinz Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Colinz Laboratories is ₹12.05 Cr as on Apr 10, 2026.
Today’s highest and lowest price of Colinz Laboratories are ₹48.51 and ₹44.00.
The 52-week high/low is the highest and lowest price at which Colinz Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Colinz Laboratories is ₹87.91 and 52-week low of Colinz Laboratories is ₹36.11 as on Apr 10, 2026.
The Colinz Laboratories has shown returns of 3.37% over the past day, 15.3% for the past month, -3.72% over 3 months, -0.48% over 1 year, 7.52% across 3 years, and 41.79% over 5 years.
P/E ratio of and PB ratio of Colinz Laboratories are 24.43 and 1.21 on Apr 10, 2026. While the company gives a dividend yield of 0.00 per annum.